ROIVANT SCIENCES LTD. purchased 40.3% of their position (5.33M shares) of SIO GENE THERAPIES INC. on the open market
Open‑market purchase worth $20.00M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/27/2020ACC: 0001104659-20-026412
10% Owner
Since Dec 2018
+5.33M
Net shares
Net buyer
$20.00M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5.33M acquired
Non-Derivative Transactions1
Common Shares, par value $0.00001 per share
Direct
Shares
+5.33M
Price / share
$3.75
Trade value
$20M
% of position
40.3%
2/24/2020
13.24M→18.58M
Total
Net shares
+5.33M
Net value
$20M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares, par value $0.00001 per share Direct | 2/24/2020 | P · Purchase | +5.33M | $3.75 | $20M | 40.3% | 13.24M | 18.58M |
| Total | +5.33M | $20M | ||||||
Derivative Transactions0
No derivative transactions reported